CA2023430A1 - Sels de 4-hydroxy-8-(3-alkoxy inferieur -4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine et procede de production - Google Patents

Sels de 4-hydroxy-8-(3-alkoxy inferieur -4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine et procede de production

Info

Publication number
CA2023430A1
CA2023430A1 CA2023430A CA2023430A CA2023430A1 CA 2023430 A1 CA2023430 A1 CA 2023430A1 CA 2023430 A CA2023430 A CA 2023430A CA 2023430 A CA2023430 A CA 2023430A CA 2023430 A1 CA2023430 A1 CA 2023430A1
Authority
CA
Canada
Prior art keywords
optically active
phenylsulfinylphenyl
pyrazolo
hydroxy
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2023430A
Other languages
English (en)
Other versions
CA2023430C (fr
Inventor
Kinji Hashimoto
Masatoshi Inai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CA2023430A1 publication Critical patent/CA2023430A1/fr
Application granted granted Critical
Publication of CA2023430C publication Critical patent/CA2023430C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002023430A 1989-08-25 1990-08-16 Sels de 4-hydroxy-8-(3-alkoxy inferieur -4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine et procede de production Expired - Fee Related CA2023430C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP219181/1989 1989-08-25
JP21918189 1989-08-25
JP2179852A JP2691317B2 (ja) 1989-08-25 1990-07-06 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法
JP179852/1990 1990-07-06

Publications (2)

Publication Number Publication Date
CA2023430A1 true CA2023430A1 (fr) 1991-02-26
CA2023430C CA2023430C (fr) 1997-11-11

Family

ID=26499580

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002023430A Expired - Fee Related CA2023430C (fr) 1989-08-25 1990-08-16 Sels de 4-hydroxy-8-(3-alkoxy inferieur -4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine et procede de production

Country Status (10)

Country Link
US (1) US5137887A (fr)
EP (1) EP0414200B1 (fr)
JP (1) JP2691317B2 (fr)
KR (1) KR960002851B1 (fr)
CN (1) CN1028528C (fr)
AU (1) AU630489B2 (fr)
CA (1) CA2023430C (fr)
DE (1) DE69021296T2 (fr)
DK (1) DK0414200T3 (fr)
ES (1) ES2075860T3 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420128A (en) * 1990-10-09 1995-05-30 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
DE69307999T2 (de) * 1992-11-27 1997-08-14 Sumitomo Spec Metals Herstellungsverfahren für einen auf Seltenerd-Eisen-Stickstoff basierter Dauermagnet
PL195762B1 (pl) * 1996-07-24 2007-10-31 Bristol Myers Squibb Pharma Co Związki [1,5-a]pirazolo-1,3,5-triazynowe, środek farmaceutyczny i zastosowanie związków [1,5-a]pirazolo-1,3,5-triazynowych do wytwarzania leku
US6124289A (en) 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
AU4331500A (en) * 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (fr) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines antagonistes de corticoliberine (crf)
MXPA02002111A (es) * 1999-08-27 2002-10-31 Abbott Lab Compuestos de sulfonilfenilpirazol utiles como inhibidores de cox-2.
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
US7329658B2 (en) * 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
US7153961B2 (en) * 2003-11-25 2006-12-26 Bristol-Myers Squibb Pharma Co. Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
JP4914210B2 (ja) * 2004-06-14 2012-04-11 日本ケミファ株式会社 縮合ピリミジン誘導体、及びキサンチンオキシダーゼ阻害剤
US20090149452A1 (en) * 2005-07-01 2009-06-11 Nippon Chemiphar Co., Ltd. Xanthine oxidase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds

Also Published As

Publication number Publication date
CA2023430C (fr) 1997-11-11
EP0414200B1 (fr) 1995-08-02
KR910004623A (ko) 1991-03-29
CN1049664A (zh) 1991-03-06
AU630489B2 (en) 1992-10-29
DE69021296T2 (de) 1996-02-01
AU6098590A (en) 1991-02-28
US5137887A (en) 1992-08-11
KR960002851B1 (ko) 1996-02-27
CN1028528C (zh) 1995-05-24
JPH03163082A (ja) 1991-07-15
EP0414200A3 (en) 1991-11-13
EP0414200A2 (fr) 1991-02-27
JP2691317B2 (ja) 1997-12-17
DK0414200T3 (da) 1995-12-27
ES2075860T3 (es) 1995-10-16
DE69021296D1 (de) 1995-09-07

Similar Documents

Publication Publication Date Title
CA2023430A1 (fr) Sels de 4-hydroxy-8-(3-alkoxy inferieur -4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine et procede de production
HU912397D0 (en) Process for producing pyrazolo-pyridine derivatives
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
CA2143107A1 (fr) .beta.-d-dioxolane-nucleosides, enantiomeres purs
HUT54278A (en) Herbicidal composition comprising triazine or pyrimidine derivative as active ingredient and process for producing the compounds
CA2160366A1 (fr) Pamoate de risperidone
CA2043440A1 (fr) Methode de traitement de l'impuissance
CA2032068A1 (fr) Pastilles pharmaceutiques
IL97826A0 (en) Ammonium salts of n5,-methyl-5,6,7,8-tetrahydrofolic acid,their preparation and pharmaceutical compositions containing them
HUT65437A (en) Process for producing 4-benzoylisoxazole derivatives, herbicidal compositions containing the compunds as active ingredients and process for using thereof
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CS405391A3 (en) N-aminobutyl-n-phenylarylamide derivatives, process of their preparationand pharmaceutical compositions containing said derivatives
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
AU4812485A (en) 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones
IE832273L (en) 7-substituted-3-vinyl-3-cephem compounds
TW252979B (fr)
IE780514L (en) Morphine derivatives
EP0445025A3 (en) Alkaline earth metal salts of oxa-polyacids, process for their preparation and pharmaceutical compositions containing them
CA2087922A1 (fr) Derives de 8-(1-aminocycloalkyl)-1,3-dialkylxanthine; methode de preparation; antidepresseur, noo-analeptique et composition psychostimulante a base de ces derives
IE872239L (en) Pyridopyrimidinediones and quinazolines
EP0855398A4 (fr) Derives de sesquiterpene a activite antivirale
CA2092510A1 (fr) Formes cristallines de chlorhydrate monohydrate d'endo-2,3-dihydro-n-(8-methyl-8-azabicyclo-[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide et de chlorhydrate monohydrate d'endo-3-ethyl-2,3-dihydro-n-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
CA2048245A1 (fr) Traitement de la cataracte avec des composes a base de prostacycline
HUT47081A (en) Process for producing pharmaceutical compositions against endogeneous parasites and a group of the active components, namely the new n-substituted oxy-carbonyl-esters

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed